Showing results (1651-1660 of 1,727) with videos related to

Sort By:
Pageof 173
ACS Chemical Biology|November 14, 2017
Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme SubfamilyJonathan D Wrigley, Gerald Gavory, Iain Simpson, et al.
Journal of the International AIDS Society|July 2, 2025
Strategies for implementing long-acting cabotegravir for PrEP in US clinics serving Black women: interim healthcare provider findings from the EBONI studyKatherine L Nelson, Tammeka Evans Cooper, Yolanda Lawson, et al.
Circulation. Cardiovascular Imaging|December 10, 2020
Coronary <sup>18</sup>F-Fluoride Uptake and Progression of Coronary Artery CalcificationMhairi K Doris, Mohammed N Meah, Alastair J Moss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
A novel mutation in CD83 results in the development of a unique population of CD4+ T cellsLeon F García-Martínez, Mark W Appleby, Karen Staehling-Hampton, et al.
The Science of the Total Environment|June 12, 2024
Associations between toxicity-weighted concentrations and dementia risk: Results from the Cardiovascular Health Cognition StudyBreanna M Crane, Kyle D Moored, Patrick T Donahue, et al.
Gastroenterology|February 8, 2022
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 StudyWilliam J Sandborn, Geert R D'Haens, Walter Reinisch, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2009
(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitorMark J Ammirati, Kim M Andrews, David D Boyer, et al.
Internal Medicine Journal|March 5, 2014
Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel diseaseE K Wright, J Williams, J M Andrews, et al.
Journal of Crohn'S & Colitis|September 16, 2022
An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative ColitisSally Mortlock, Anton Lord, Grant Montgomery, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosingClifford D Jones, David M Andrews, Andrew J Barker, et al.
Pageof 173